Innova-Tech Consulting
5
9M
5
0.25
2
- Stages of investment
- Areas of investment
Summary
In 2002 was created Innova-Tech Consulting, which is appeared as Corporate Investor.
Comparing to the other companies, this Innova-Tech Consulting performs on 21 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2017. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2005. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Innova-Tech Consulting, startups are often financed by iNovia Capital, Universitu00e9 de Sherbrooke, Sociu00e9tu00e9 Innovatech du sud du Quu00e9bec. The meaningful sponsors for the fund in investment in the same round are Desjardins Venture Capital, iNovia Capital, Ventures West. In the next rounds fund is usually obtained by OrbiMed, Lothian Partners, Desjardins Venture Capital.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Transportation, Genetics. Among the most popular portfolio startups of the fund, we may highlight Enobia Pharma, Zeligsoft, SiXtron Advanced Materials.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.25
- Investments by industry
- Health Care (2)
- Medical (1)
- Genetics (1)
- Biotechnology (1)
- Information Technology (1) Show 8 more
- Investments by region
-
- Canada (4)
- Poland (1)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Group Appearance index
- 1.00
- Avg. company exit year
- 14
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Libera Bio | 19 Jul 2022 | Health Care | Seed | 1M | Malopolskie, Kraków, Poland |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.